Tuesday morning snapshot

A snapshot of the early morning's equity news and key market movements.

Last night in the US: The Dow Jones closed up 26 points at 16,743, the NASDAQ finished down five points at 4237 and the S&P 500 ended the day up one points at 1924.

This morning in London: The FTSE 100 is currently down 14 points at 6848.

FX and commodities: GBP/USD is up 12 pips at $1.6757, EUR/USD is up seven pips at $1.3604 and USD/JPY is down three pips at ¥102.34. Brent crude is up 11 cents at $108.87 and gold is trading at $1245, up $1.

Stocks: AstraZeneca has announced that the FDA has fast tracked its latest antibiotic drug. More bad news for G4S as a government watchdog is now investigating the company’s activities in Palestine and Israel. Wolseley has stated it expects the next half year to see revenue grow by 4%.  

The day ahead: UK construction purchasing managers index figures are out this morning, along with the eurozone current unemployment rate and yearly flash consumer price index estimates. Later in the afternoon we will see US monthly factory orders.

All figures correct at 8.20am. All times London time.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money. Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.